• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Picrasidine I Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5762948

Picrasidine I has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, NF-kappaB and ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Picrasidine I, Inhibitor
Full Product Name
Picrasidine I
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
240.3
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C14H12N2O2
CAS Number
100234-59-1
Target & IC50
c-Fos
MAPK
NF-kappaB
NFATc1
ROS

Other Notes

Small volumes of Picrasidine I, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Picrasidine I purchase

MBS5762948 is an inhibitor targeting Picrasidine I.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000